Journal of Translational Internal Medicine

Papers
(The H4-Index of Journal of Translational Internal Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Acute kidney injury associated with severe hypouricemia caused by a novel SLC2A9 mutation: Enlightenment from rare disease to common disease117
Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma70
Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy62
Development and status quo of digestive endoscopy in China: An analysis based on the national census in 2013 and 202059
Artificial intelligence for disease X: Progress and challenges57
Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphoma49
Circulating exosome long non-coding RNAs are associated with atrial structural remodeling by increasing systemic inflammation in atrial fibrillation patients49
A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma48
Co-targeting ferroptosis and immune evasion through small molecules in breast cancer43
The long and the short of current nanomedicines for treating Alzheimer's disease42
Artificial intelligence in glycemic management for diabetes: Applications, opportunities and challenges40
Recognition of differently expressed genes and DNA methylation markers in patients with Lupus nephritis39
Role of viral hepatitis in pregnancy and its triggering mechanism39
Protein kinase B is involved in bisphenol A-induced macrophage polarization through mechanistic target of rapamycin-dependent autophagy37
Reperfusion therapy for acute ischemic stroke: Where we are and where to go36
Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model34
Current applications and future perspectives of artificial intelligence in valvular heart disease33
Obesity and coronavirus disease 201931
Suggestions on home quarantine and recovery of novel coronavirus patients30
Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China29
Artificial intelligence in rheumatology: A transformative perspective29
Senescent cells as a target for anti-aging interventions: From senolytics to immune therapies28
The multi-modal digital heart: From future perspective to challenges28
Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice through upregulation of the RAS/ERK signaling pathway28
Insufficiency of quality of life as the treatment endpoint for balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension27
Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models26
0.059525966644287